All stocks today
68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Astellas Pharma Inc. revenue reports

Astellas Pharma Inc. financial reports, Astellas Pharma Inc. annual revenue in 2019. When does Astellas Pharma Inc. report revenue?
Add to widgets
Added to widgets
Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 301 320 000 000 $ - 30 730 000 000 $ -
31/12/2018 357 932 000 000 $ - 87 669 000 000 $ -
30/09/2018 318 011 000 000 $ - 49 307 000 000 $ -
30/06/2018 329 085 000 000 $ - 54 559 000 000 $ -
Show:
to

Astellas Pharma Inc. financial report charts

Astellas Pharma Inc. quarterly report dates

  31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
236 981 000 000 $ 273 761 000 000 $ 245 207 000 000 $ 258 349 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
64 339 000 000 $ 84 171 000 000 $ 72 804 000 000 $ 70 736 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
301 320 000 000 $ 357 932 000 000 $ 318 011 000 000 $ 329 085 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
35 211 000 000 $ 83 030 000 000 $ 63 643 000 000 $ 63 801 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
30 730 000 000 $ 87 669 000 000 $ 49 307 000 000 $ 54 559 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
58 723 000 000 $ 50 393 000 000 $ 47 433 000 000 $ 52 132 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
266 109 000 000 $ 274 902 000 000 $ 254 368 000 000 $ 265 284 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
857 159 000 000 $ 890 258 000 000 $ 845 514 000 000 $ 844 734 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 897 648 000 000 $ 1 928 325 000 000 $ 1 886 926 000 000 $ 1 866 551 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
311 074 000 000 $ 331 296 000 000 $ 306 867 000 000 $ 309 741 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
497 665 000 000 $ 494 592 000 000 $ 447 580 000 000 $ 438 647 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
639 252 000 000 $ 636 116 000 000 $ 604 241 000 000 $ 590 630 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
33.69 % 32.99 % 32.02 % 31.64 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 258 396 000 000 $ 1 292 209 000 000 $ 1 282 685 000 000 $ 1 275 921 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
54 949 000 000 $ 91 595 000 000 $ 74 907 000 000 $ 37 179 000 000 $

Last revenue report of Astellas Pharma Inc. was 31/03/2019. According to last financial report total revenue in Astellas Pharma Inc. was 301 320 000 000 US dollar and changed by 0% since last year. Net income in Astellas Pharma Inc. was 30 730 000 000 $ in last quartal, net income changes to 0%.

Astellas Pharma Inc. stocks data

Astellas Pharma Inc. financials